Zobrazeno 1 - 9
of 9
pro vyhledávání: '"John D. Doty"'
Autor:
James M. Robinson, Mellisa Wheeler, Kathryn Finch Mileham, Edward S. Kim, James Oliver, Kia Dungan, Derek Raghavan, Darcy L. Doege, Lauren Davis, Henri Levy, Daniel R. Carrizosa, John D. Doty
Publikováno v:
The Oncologist
Introduction The National Lung Screening Trial (NLST) demonstrated that screening high‐risk patients with low‐dose computed tomography (CT) of the chest reduces lung cancer mortality compared with screening with chest x‐ray. Uninsured and Medic
Autor:
Brooke Weatherford, John D. Doty, Kathryn Finch Mileham, Derek Raghavan, Daniel R. Carrizosa, Mellisa Wheeler, Darcy L. Doege, Stephanie White, Kia Dungan, Lauren Davis, Glenn Hickman
Publikováno v:
Journal of Clinical Oncology. 39:6540-6540
6540 Background: Studies such as the National Lung Screening Trial (NLST; N Engl J Med 2011;365:395-409) have shown a survival benefit to low-dose Lung CT screening in high-risk smokers. Levine Cancer Institute (LCI) initiated the first mobile low do
Autor:
Darcy L. Doege, Lauren Davis, Kathryn Finch Mileham, John D. Doty, Mellisa Wheeler, Stephanie White, Derek Raghavan, Kia Dungan, Brooke Weatherford, Glenn Hickman, Daniel R. Carrizosa
Publikováno v:
Journal of Clinical Oncology. 39:6507-6507
6507 Background: Randomized trials have proven that screening high-risk patients with LDCT of chest reduces lung cancer mortality compared to screening with chest x-ray. Under-served patients lack access to this test due to geographic and socio-econo
Autor:
Daniel R. Carrizosa, Derek Raghavan, James Oliver, Kathryn Finch Mileham, John D. Doty, Mellisa Wheeler, Darcy L. Doege, Edward S. Kim
Publikováno v:
Journal of Clinical Oncology. 37:6567-6567
6567 Background: The National Lung Screening Trial (NLST) demonstrated that screening high-risk patients with low-dose CT (LDCT) of the chest reduces lung cancer mortality compared to screening with chest x-ray. Uninsured and Medicaid patients lack a
Publikováno v:
Pharmacotherapy. 23:1668-1672
A 30-g venlafaxine overdose resulted in death for a 39-year-old woman whose 43-day clinical course was highlighted by refractory hypotension and the resulting complications of bowel ischemia and perforation. Her venlafaxine and O-desmethylvenlafaxine
Publikováno v:
Chest. 124:2023-2026
Background/objectives Many patients with neurosarcoidosis have disease that is refractory to corticosteroids or they are unable to tolerate high-dose corticosteroids because of detrimental side effects. We examined a short-course, pulse-dose regimen
Autor:
John D. Doty, Steven A. Sahn
Publikováno v:
Southern Medical Journal. 96:923-925
The case of a 49-year-old alcoholic man with obtundation is presented. The patient was presumptively diagnosed with methanol intoxication due to the presence of metabolic acidosis with high anion and osmolar gaps. Laboratory testing revealed toxic le
Publikováno v:
Chest. 127(3)
Background/objectives Many patients with sarcoidosis are unable to tolerate corticosteroids or alternative therapeutic agents due to side effects or have disease refractory to these agents. We report our experience using infliximab to treat such pati
Publikováno v:
The Journal of urology. 132(1)
Chemotherapy for a metastatic germ cell tumor of the testis was complicated by a life-threatening bronchial rupture secondary to lysis of an endobronchial tumor. Subsequent chemotherapy was delayed because of this complication. Other pulmonary compli